Related Experiment Video
Updated: Jul 17, 2026

15:17
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
Microarrays for cancer diagnosis and classification
Ainhoa Perez-Diez1, Andrey Morgun, Natalia Shulzhenko
1Ghost Lab, Laboratory of Cellular and Molecular Immunology, NIAID, NIH, USA. aperezdiez@niaid.nih.gov
Advances in Experimental Medicine and Biology
|February 3, 2007
Summary
Microarray analysis offers refined methods for cancer diagnosis and classification, improving accuracy and identifying novel tumor markers. Integrated analysis of public data promises widespread clinical use for gene profiling in hematological and solid tumors.
Area of Science:
- Genomics
- Cancer Research
- Bioinformatics
Background:
- Microarray analysis is increasingly reported in cancer research but lacks widespread clinical acceptance for diagnosis and classification.
- Existing microarray studies primarily focus on specific tumor types, limiting universal application in clinical laboratories.
Purpose of the Study:
- To discuss refined analytical approaches for microarray data in cancer diagnosis and classification.
- To demonstrate how to derive reliable gene profiles from microarray data for clinical laboratory use.
- To highlight the potential of microarray technology in improving cancer diagnostics and discovering novel tumor markers.
Main Methods:
- Class comparison, class prediction, and class discovery methods for analyzing microarray data.
- Utilizing examples from major experimental contributions in hematological and solid tumors.
- Emphasis on integrated analysis of publicly available microarray datasets.
Main Results:
- Microarray technology can yield general and reliable gene profiles suitable for universal clinical application.
- Microarray analysis can enhance the accuracy of traditional diagnostic techniques by identifying novel tumor-specific markers.
- Publicly available data and integrated analysis are crucial for realizing the potential of microarrays in cancer diagnosis.
Conclusions:
- Refined microarray data analysis methods are essential for clinical adoption in cancer diagnosis and classification.
- Microarray technology serves as a valuable tool for improving diagnostic accuracy and discovering new cancer biomarkers.
- The integration of public microarray data is key to unlocking the full potential of this technology for cancer care.
